ECONOMIC EVALUATION OF FLUOXETINE, SERTRALINE, AND ESCITALOPRAM THERAPY FOR PATIENT DIAGNOSED WITH DEPRESSIVE DISORDER
The access to proper medication for patients diagnosed with depression is still low, where only nine percent of the patients receive medical treatment. Thus, accessibility to affordable therapy is a factor to consider. This study aimed to compare the cost and effectiveness of antidepressant thera...
Saved in:
Main Author: | Abdul Hafidz, Kholid |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/62983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: A pharmacoeconomic evaluation
by: Ronnachai Kongsakon, et al.
Published: (2018) -
Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label study
by: Maneeton N., et al.
Published: (2014) -
Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label study
by: Narong Maneeton, et al.
Published: (2018) -
An open, baseline controlled evaluation of sertraline safety and efficacy in the treatment of depression in Thai patients
by: Boonyanaruthee V., et al.
Published: (2014) -
An open, baseline controlled evaluation of sertraline safety and efficacy in the treatment of depression in Thai patients
by: Vudhichai Boonyanaruthee, et al.
Published: (2018)